Advanced search
1 file | 524.71 KB Add to list

Regulatory development of geriatric medicines : to GIP or not to GIP?

(2016) AGEING RESEARCH REVIEWS. 27. p.23-36
Author
Organization
Keywords
Geriatric, Regulatory affairs, Drug formulation, Drug development, Aging, Clinical trials, BLOOD-BRAIN-BARRIER, ADVERSE DRUG-REACTIONS, QUALITY-OF-LIFE, OLDER-PEOPLE, CLINICAL-TRIALS, ALZHEIMERS-DISEASE, AGE, DELIVERY, ADULTS, PHARMACOKINETICS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 524.71 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Spiegeleer, Bart et al. “Regulatory Development of Geriatric Medicines : to GIP or Not to GIP?” AGEING RESEARCH REVIEWS 27 (2016): 23–36. Print.
APA
De Spiegeleer, B., Wynendaele, E., Bracke, N., Veryser, L., Taevernier, L., Degroote, A., & Stalmans, S. (2016). Regulatory development of geriatric medicines : to GIP or not to GIP? AGEING RESEARCH REVIEWS, 27, 23–36.
Chicago author-date
De Spiegeleer, Bart, Evelien Wynendaele, Nathalie Bracke, Lieselotte Veryser, Lien Taevernier, Agnes Degroote, and Sofie Stalmans. 2016. “Regulatory Development of Geriatric Medicines : to GIP or Not to GIP?” Ageing Research Reviews 27: 23–36.
Chicago author-date (all authors)
De Spiegeleer, Bart, Evelien Wynendaele, Nathalie Bracke, Lieselotte Veryser, Lien Taevernier, Agnes Degroote, and Sofie Stalmans. 2016. “Regulatory Development of Geriatric Medicines : to GIP or Not to GIP?” Ageing Research Reviews 27: 23–36.
Vancouver
1.
De Spiegeleer B, Wynendaele E, Bracke N, Veryser L, Taevernier L, Degroote A, et al. Regulatory development of geriatric medicines : to GIP or not to GIP? AGEING RESEARCH REVIEWS. 2016;27:23–36.
IEEE
[1]
B. De Spiegeleer et al., “Regulatory development of geriatric medicines : to GIP or not to GIP?,” AGEING RESEARCH REVIEWS, vol. 27, pp. 23–36, 2016.
@article{7097546,
  author       = {De Spiegeleer, Bart and Wynendaele, Evelien and Bracke, Nathalie and Veryser, Lieselotte and Taevernier, Lien and Degroote, Agnes and Stalmans, Sofie},
  issn         = {1568-1637},
  journal      = {AGEING RESEARCH REVIEWS},
  keywords     = {Geriatric,Regulatory affairs,Drug formulation,Drug development,Aging,Clinical trials,BLOOD-BRAIN-BARRIER,ADVERSE DRUG-REACTIONS,QUALITY-OF-LIFE,OLDER-PEOPLE,CLINICAL-TRIALS,ALZHEIMERS-DISEASE,AGE,DELIVERY,ADULTS,PHARMACOKINETICS},
  language     = {eng},
  pages        = {23--36},
  title        = {Regulatory development of geriatric medicines : to GIP or not to GIP?},
  url          = {http://dx.doi.org/10.1016/j.arr.2016.02.004},
  volume       = {27},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: